$DYAI “Now let me add some more color to that. I think that our pipeline is bulging at the moment to some degree. Now whether these get through legal departments. We have a variety of stages of where we're negotiating potential deals as we speak today, all the way to starting new deals. And a lot of those are with Big Pharma and some of those are with biotech. Some are in animal health. Some are in human health. Some of those are with CDMOs that are contract manufacturers that a lot of these pharma companies are saying, "Well, find us a CDMO that will run C1." And we -- that will even accelerate things faster. So we just say stay tuned, but yes, we expect more deals to be done and we expect at least 1 or 2, maybe more, even in Q2 to be announced.”
  • 3
  • 4